Skip to main content
Cyclerion Therapeutics, Inc. logo

Cyclerion Therapeutics, Inc. — Investor Relations & Filings

Ticker · CYCN ISIN · US23255M1053 US Manufacturing
Filings indexed 338 across all filing types
Latest filing 2024-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US CYCN

About Cyclerion Therapeutics, Inc.

https://www.cyclerion.com/

Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to advancing personalized therapeutic approaches for neuropsychiatric disorders. The company's primary focus is on developing a treatment for people with Treatment-Resistant Depression (TRD). Its lead program utilizes a method that combines generic anesthetics with a personalized, biofeedback-driven device. This approach is designed to reset dysregulated brainwave patterns by tailoring the therapy to each patient's specific biological needs, offering a new option for individuals who have not responded to traditional treatments.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2024
2024-05-07 English
DEFA14A
Regulatory Filings
2024-04-29 English
DEF 14A
Proxy Solicitation & Information Statement
2024-04-29 English
8-K
Regulatory Filings
2024-04-18 English
3
Director's Dealing
2024-03-11 English
10-K
Annual Report FY 2023
2024-03-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.